• 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • FREE continuing education credit is available for the following session:

    "Decisional Capacity"

    (session captured at the GAPNA 2018 Annual Conference)


    For July/August 2019 - Get Your Free CNE Now!

  • Save $90 - Register Now with Early Bird Savings!
    38th Annual GAPNA Conference

    October 3-5, 2019 at the Paris Hotel, Las Vegas, NV.

    Focused education; lasting connections, networking, free access to the GAPNA Online Library.

    Earn up to 22 contact hours (including pre-conference workshops).

    Get more information and register now!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

Risk of Death Increases in Nursing Home Residents After Exposure to Typical Antipsychotics

Older antipsychotic medications, called typical antipsychotics, can cause a variety of central nervous system side effects.

The newer, atypical agents are preferred by many due to their better side effect profiles. Typical antipsychotics can increase the risk for mortality in the elderly, conclude researchers.

Researchers analyzed Medicare and Medicaid data on 3,609 typical antipsychotic users matched with 3,609 atypical antipsychotic users. Residents who used atypical antipsychotics had an unadjusted mortality rate of 18.42% compared with 24.06% for users of typical antipsychotics. On average, there was a 41% higher risk of death within 180 days of exposure to typical agents compared to treatment with atypical agents.

The researchers advise physicians to base their decisions to use antipsychotics in this population on individual risk factors as well as the acute and long-term risks of therapy. Since dual-eligible residents are particularly vulnerable, they should be closely monitored once antipsychotic treatment is started.

For more info, see Aparasu et al. (2012). Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents. Medical Care, 50(11), 961-968. doi:10.1097/MLR.0b013e31826ec185

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: